Pricing
Login
Home
Charts
Search
Watchlist
Products

Dr Reddys Laboratories Ltd

DRREDDY
₹1,390.20-0.76%20 Nov 2026
Reports
Pharma Formulations

Dr Reddys Laboratories Ltd

DRREDDY
₹1,390.20
-0.76%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,16,119Cr
Close
Close Price
₹1,390.20
Industry
Industry
Pharma Formulations
PE
Price To Earnings
41.36
PS
Price To Sales
3.51
Revenue
Revenue
₹33,097Cr
Rev Gr TTM
Revenue Growth TTM
-3.53%
PAT Gr TTM
PAT Growth TTM
-51.90%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7,2377,1147,6968,0388,3818,5288,5728,8288,7537,5468,1008,698
Growth YoY
Revenue Growth YoY%
6.612.713.916.415.819.911.49.84.4-11.5-5.5-1.5
Expenses
ExpensesCr
5,2145,2835,5665,9626,1086,5316,3996,8186,8667,1647,2406,967
Operating Profit
Operating ProfitCr
2,0231,8312,1302,0772,2731,9982,1742,0101,8883838601,731
OPM
OPM%
28.025.727.725.827.123.425.422.821.65.110.619.9
Other Income
Other IncomeCr
219201193314154528291330271480356149
Interest Expense
Interest ExpenseCr
395960768266839194106126125
Depreciation
DepreciationCr
374368381397471455476505521557537527
PBT
PBTCr
1,8291,6051,8831,9171,8742,0051,9051,7451,5432005531,228
Tax
TaxCr
448295490576470419495408354-22118314
PAT
PATCr
1,3811,3101,3921,3421,4041,5871,4101,3371,190221436913
Growth YoY
PAT Growth YoY%
11.036.4-0.9-9.51.721.11.3-0.4-15.3-86.0-69.1-31.7
NPM
NPM%
19.118.418.116.716.818.616.415.113.62.95.410.5
EPS
EPS₹
16.615.716.715.117.019.117.016.214.52.65.311.1
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
7,2377,1147,6968,0388,3818,5288,5728,8288,7537,5468,1008,698
Growth YoY
Revenue Growth YoY%
6.612.713.916.415.819.911.49.84.4-11.5-5.5-1.5
Expenses
ExpensesCr
5,2145,2835,5665,9626,1086,5316,3996,8186,8667,1647,2406,967
Operating Profit
Operating ProfitCr
2,0231,8312,1302,0772,2731,9982,1742,0101,8883838601,731
OPM
OPM%
28.025.727.725.827.123.425.422.821.65.110.619.9
Other Income
Other IncomeCr
219201193314154528291330271480356149
Interest Expense
Interest ExpenseCr
395960768266839194106126125
Depreciation
DepreciationCr
374368381397471455476505521557537527
PBT
PBTCr
1,8291,6051,8831,9171,8742,0051,9051,7451,5432005531,228
Tax
TaxCr
448295490576470419495408354-22118314
PAT
PATCr
1,3811,3101,3921,3421,4041,5871,4101,3371,190221436913
Growth YoY
PAT Growth YoY%
11.036.4-0.9-9.51.721.11.3-0.4-15.3-86.0-69.1-31.7
NPM
NPM%
19.118.418.116.716.818.616.415.113.62.95.410.5
EPS
EPS₹
16.615.716.715.117.019.117.016.214.52.65.311.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,70033,097
Growth
Revenue Growth%
3.6-8.80.68.213.48.713.114.513.516.53.2-3.5
Expenses
ExpensesCr
11,98311,72411,93012,27015,04715,17817,77818,32120,07824,09727,24728,237
Operating Profit
Operating ProfitCr
3,5852,4722,3513,1782,4703,8703,7686,3497,9338,5476,4544,861
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.114.7
Other Income
Other IncomeCr
2951721553816773395551,0939091,1191,3721,255
Interest Expense
Interest ExpenseCr
83637989989796143171283374450
Depreciation
DepreciationCr
9391,0271,0771,1351,1631,2291,1651,2501,4701,7042,0592,141
PBT
PBTCr
2,8591,5541,3502,3361,8862,8843,0616,0497,2017,6805,3933,524
Tax
TaxCr
751297438386-1409328791,5411,6231,9541,235764
PAT
PATCr
2,1081,2579121,9502,0261,9522,1834,5075,5785,7254,1582,760
Growth
PAT Growth%
-9.8-40.4-27.4113.73.9-3.711.8106.523.82.6-27.4-51.9
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.38.3
EPS
EPS₹
25.015.511.423.524.423.526.354.367.067.950.433.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
15,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,70033,097
Growth
Revenue Growth%
3.6-8.80.68.213.48.713.114.513.516.53.2-3.5
Expenses
ExpensesCr
11,98311,72411,93012,27015,04715,17817,77818,32120,07824,09727,24728,237
Operating Profit
Operating ProfitCr
3,5852,4722,3513,1782,4703,8703,7686,3497,9338,5476,4544,861
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.114.7
Other Income
Other IncomeCr
2951721553816773395551,0939091,1191,3721,255
Interest Expense
Interest ExpenseCr
83637989989796143171283374450
Depreciation
DepreciationCr
9391,0271,0771,1351,1631,2291,1651,2501,4701,7042,0592,141
PBT
PBTCr
2,8591,5541,3502,3361,8862,8843,0616,0497,2017,6805,3933,524
Tax
TaxCr
751297438386-1409328791,5411,6231,9541,235764
PAT
PATCr
2,1081,2579121,9502,0261,9522,1834,5075,5785,7254,1582,760
Growth
PAT Growth%
-9.8-40.4-27.4113.73.9-3.711.8106.523.82.6-27.4-51.9
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.38.3
EPS
EPS₹
25.015.511.423.524.423.526.354.367.067.950.433.6
Sales CAGR
1 Year3%
3 Years11%
5 Years12%
TTM-4%
EBITDA CAGR
1 Year-24%
3 Years1%
5 Years11%
TTM-43%
PAT CAGR
1 Year-27%
3 Years-3%
5 Years16%
TTM-52%
Avg. ROCE
1 Year13%
3 Years19%
5 Years19%
TTM9%
CFO / EBITDA
1 Year88%
3 Years65%
5 Years71%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
858383838383838383838484
Reserves
ReservesCr
12,48512,17912,48913,99415,61617,75519,28923,33028,17133,46637,99038,724
Current Liabilities
Current LiabilitiesCr
6,3478,4206,8945,8977,2148,1049,7668,5729,58813,03416,74715,430
Non Current Liabilities
Non Current LiabilitiesCr
1,4671,1353,0792,5454128717694271,0212,4653,1453,075
Total Liabilities
Total LiabilitiesCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,12357,631
Current Assets
Current AssetsCr
11,7949,68410,49811,11012,59914,55017,78220,42624,80525,01830,17929,732
Non Current Assets
Non Current AssetsCr
8,59012,13312,04611,35610,62612,06711,96511,86014,05924,40927,94427,899
Total Assets
Total AssetsCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,12357,631
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
858383838383838383838484
Reserves
ReservesCr
12,48512,17912,48913,99415,61617,75519,28923,33028,17133,46637,99038,724
Current Liabilities
Current LiabilitiesCr
6,3478,4206,8945,8977,2148,1049,7668,5729,58813,03416,74715,430
Non Current Liabilities
Non Current LiabilitiesCr
1,4671,1353,0792,5454128717694271,0212,4653,1453,075
Total Liabilities
Total LiabilitiesCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,12357,631
Current Assets
Current AssetsCr
11,7949,68410,49811,11012,59914,55017,78220,42624,80525,01830,17929,732
Non Current Assets
Non Current AssetsCr
8,59012,13312,04611,35610,62612,06711,96511,86014,05924,40927,94427,899
Total Assets
Total AssetsCr
20,38421,81722,54422,46623,22526,61729,74732,28538,86449,42758,12357,631

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Investing Cash Flow
Investing Cash FlowCr
-2,039-1,840-1,488-773-492-2,266-2,639-4,137-4,028-5,808-6,549
Financing Cash Flow
Financing Cash FlowCr
-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow
Net Cash FlowCr
-477-65-129-35-241,275-70-936139726-47
Free Cash Flow
Free Cash FlowCr
2,0659268882,3012,5133,5792,8484,7633,0091,9443,374
CFO To PAT
CFO To PAT%
154.8170.6197.6147.2147.3182.9128.8130.681.581.1136.5
CFO To EBITDA
CFO To EBITDA%
91.086.776.790.3120.892.374.692.757.354.387.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Investing Cash Flow
Investing Cash FlowCr
-2,039-1,840-1,488-773-492-2,266-2,639-4,137-4,028-5,808-6,549
Financing Cash Flow
Financing Cash FlowCr
-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow
Net Cash FlowCr
-477-65-129-35-241,275-70-936139726-47
Free Cash Flow
Free Cash FlowCr
2,0659268882,3012,5133,5792,8484,7633,0091,9443,374
CFO To PAT
CFO To PAT%
154.8170.6197.6147.2147.3182.9128.8130.681.581.1136.5
CFO To EBITDA
CFO To EBITDA%
91.086.776.790.3120.892.374.692.757.354.387.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
51,77843,63234,55046,06951,79875,09571,65376,9611,02,67995,4661,04,7201,16,119
Price To Earnings
Price To Earnings
24.333.836.523.625.638.532.817.118.416.925.041.4
Price To Sales
Price To Sales
3.33.12.43.03.03.93.33.13.72.93.13.5
Price To Book
Price To Book
4.13.62.83.33.34.23.73.33.62.82.83.0
EV To EBITDA
EV To EBITDA
15.219.516.715.521.619.619.312.113.011.416.924.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.265.663.059.558.258.156.260.061.359.955.455.4
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.114.7
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.38.3
ROCE
ROCE%
18.59.48.113.911.314.313.925.024.420.812.68.9
ROE
ROE%
16.810.37.313.812.910.911.319.319.717.110.97.1
ROA
ROA%
10.35.84.08.78.77.37.314.014.311.67.24.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
51,77843,63234,55046,06951,79875,09571,65376,9611,02,67995,4661,04,7201,16,119
Price To Earnings
Price To Earnings
24.333.836.523.625.638.532.817.118.416.925.041.4
Price To Sales
Price To Sales
3.33.12.43.03.03.93.33.13.72.93.13.5
Price To Book
Price To Book
4.13.62.83.33.34.23.73.33.62.82.83.0
EV To EBITDA
EV To EBITDA
15.219.516.715.521.619.619.312.113.011.416.924.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
67.265.663.059.558.258.156.260.061.359.955.455.4
OPM
OPM%
23.017.416.520.614.120.317.525.728.326.219.114.7
NPM
NPM%
13.58.96.412.611.610.310.118.319.917.512.38.3
ROCE
ROCE%
18.59.48.113.911.314.313.925.024.420.812.68.9
ROE
ROE%
16.810.37.313.812.910.911.319.319.717.110.97.1
ROA
ROA%
10.35.84.08.78.77.37.314.014.311.67.24.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Market CapitalizationMkt CapCr4,52,2511,78,3741,19,7001,16,1191,14,3161,10,0771,03,510
Close PriceClose₹1,884.904,689.501,200.001,390.201,415.002,665.001,799.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE41.2579.2128.6741.3639.4549.0526.09
Price To SalesPS7.3410.253.943.514.067.162.80
RevenueRevenueCr61,63117,40030,37833,09728,13915,37936,913
Revenue Growth TTMRev Gr TTM%12.1%42.1%24.0%-3.5%-0.7%13.5%13.5%
PAT Growth TTMPAT Gr TTM%4.9%-1.9%-14.6%-51.9%-47.4%27.6%16.5%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews